Diagnostic Workup and Treatment for Hair Loss in Young Females

Initial Diagnostic Approach

The British Journal of Dermatology recommends determining the pattern of hair loss, such as diffuse, patchy, or patterned distribution, to guide diagnosis and treatment 1
Examination for characteristic features like exclamation mark hairs, broken hairs, or inflammation is crucial for diagnosis, as suggested by the British Journal of Dermatology 1
Dermoscopy can identify diagnostic features of alopecia areata, including yellow dots, dystrophic hairs, and cadaverized hairs, according to the British Journal of Dermatology 1

Alopecia areata is characterized by well-defined patches of hair loss with exclamation mark hairs, as described by the British Journal of Dermatology 2
Trichotillomania is marked by incomplete hair loss with broken hairs firmly anchored in the scalp, as noted by the British Journal of Dermatology 1
Early scarring alopecia requires prompt dermatology referral, as emphasized by the British Journal of Dermatology 1

The British Journal of Dermatology suggests that laboratory testing should be selective and guided by clinical suspicion rather than performed routinely 1
Fungal culture should be considered when tinea capitis is suspected, according to the British Journal of Dermatology 1
Skin biopsy may be necessary when diagnosis remains uncertain or to rule out scarring alopecia, as recommended by the British Journal of Dermatology 1
Testing for autoimmune conditions is not routinely recommended unless clinically indicated, as stated by the British Journal of Dermatology 1
Iron studies are not recommended routinely, as studies have not confirmed a consistent association between iron deficiency and alopecia areata, according to the British Journal of Dermatology 1

Intralesional corticosteroid injections are the first-line treatment for limited patchy hair loss, as recommended by the British Journal of Dermatology 3, 4
Contact immunotherapy may be considered for extensive patchy hair loss, though availability is limited, as noted by the British Journal of Dermatology 4
Potent topical corticosteroids, such as clobetasol propionate, may be used, though evidence for effectiveness is limited, according to the British Journal of Dermatology 2, 5
Topical minoxidil may be prescribed, but has limited evidence in alopecia areata, as stated by the British Journal of Dermatology 4

The psychological impact of hair loss in young women is significant and should be addressed, as emphasized by the British Journal of Dermatology 6
Counseling about the nature and course of the disease is essential, as recommended by the British Journal of Dermatology 6
Referral for psychological support should be considered for patients experiencing significant distress, as suggested by the British Journal of Dermatology 6
Cosmetic options, such as wigs or hairpieces, should be discussed, particularly for extensive hair loss, as noted by the British Journal of Dermatology 3
Patients should be warned about possible relapse following initially successful treatment, as stated by the British Journal of Dermatology 2

Hazardous treatments with unproven efficacy should be avoided, as many cases of alopecia areata resolve spontaneously, according to the British Journal of Dermatology 6
Continuous or pulsed systemic corticosteroids and PUVA therapy should be used with caution due to potential serious side effects, as noted by the British Journal of Dermatology 4
Treatment response may be poor in longstanding extensive alopecia, as stated by the British Journal of Dermatology 2
Intralesional corticosteroids may be poorly tolerated in children, as noted by the British Journal of Dermatology 4
Contact immunotherapy may cause pigmentary complications in patients with racially pigmented skin, as warned by the British Journal of Dermatology 7

Follow-up should be scheduled at 3 months to assess treatment response, as recommended by the British Journal of Dermatology 2
Written instructions for self-monitoring and when to seek further medical attention should be provided, as suggested by the British Journal of Dermatology 2
Longer follow-up may be considered for patients with extensive, persistent, or atypical disease, as noted by the British Journal of Dermatology 2